Try our one-month starter plans
Listen to this article Copyright © DrugPatentWatch. Originally published at Try our one-month starter plans Do you want an easier way to access DrugPatentWatch without a long-term commitment? We have monthly…
Read more
Make better decisions with advanced biopharmaceutical business intelligence
Listen to this article Copyright © DrugPatentWatch. Originally published at Make better decisions with advanced biopharmaceutical business intelligence What can we build for you? Do you have special business intelligence…
Read more
Generic Drug Launch Dates – A 1-step Solution to Navigate the Web of Drug Patents and Regulatory Protections
Listen to this article Copyright © DrugPatentWatch. Originally published at Generic Drug Launch Dates – A 1-step Solution to Navigate the Web of Drug Patents and Regulatory Protections Drugs can…
Read more
3 Uses for Historical Versions of the FDA Orange Book
Listen to this article Copyright © DrugPatentWatch. Originally published at 3 Uses for Historical Versions of the FDA Orange Book Officially known as Approved Drug Products With Therapeutic Equivalence Evaluations,…
Read more
Make Better Decisions With DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at Make Better Decisions With DrugPatentWatch MAKE BETTER DECISIONS Join the 500+ leading biopharmaceutical companies we have served and make better decisions with DrugPatentWatch’s deep…
Read more
Integrate DrugPatentWatch Into Your Application or Data Store
Copyright © DrugPatentWatch. Originally published at Integrate DrugPatentWatch Into Your Application or Data Store Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs…
Read more
What are the top Biopharmaceutical Business Intelligence Services?
Copyright © DrugPatentWatch. Originally published at What are the top Biopharmaceutical Business Intelligence Services? A guide for portfolio managers, business analysts, formulary directors, and more… Navigating the myriad service providers…
Read more
Ranking Biotechnology Innovation Country-by-Country
Copyright © DrugPatentWatch. Originally published at Ranking Biotechnology Innovation Country-by-Country Where does your country rank? Applications of biotechnology range from advanced medicines to and improvements in agriculture and biofuels, and…
Read more
Publish With DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at Publish With DrugPatentWatch Share your expertise with our expansive network > Go to submission form < Do you want to reach a large and…
Read more

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare
and is included in one NDA. There are two patents protecting this compound.

This ingredient has seventy-one patent family members in thirty-seven countries.

Three suppliers are listed for this compound. There is one tentative approval for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Published in Tentative Approval

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Share this:

Related